Marshall Fordyce insider trades: Vera Therapeutics (VERA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Marshall reports to the SEC
Open-market buys and sales
29 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | VERA | ↓ Sell | 18,500 | $37.00 | $685K | Direct | Sep 17, 2026 (2d) |
| Sep 2, 2026 | VERA | ↓ Sell | 18,500 | $35.12 | $650K | Direct | Sep 4, 2026 (2d) |
| Jul 7, 2026 | VERA | ↓ Sell | 46,250 | $42.30 | $2.0M | Direct | Aug 12, 2026 (36d) |
| Jul 7, 2026 | VERA | ↓ Sell | 46,250 | $42.30 | $2.0M | Direct | Jul 9, 2026 (2d) |
| Jun 23, 2026 | VERA | ↓ Sell | 18,500 | $37.93 | $702K | Direct | Aug 12, 2026 (50d) |
| Jun 23, 2026 | VERA | ↓ Sell | 18,500 | $37.93 | $702K | Direct | Jun 24, 2026 (1d) |
| May 12, 2026 | VERA | ↓ Sell | 18,500 | $36.74 | $680K | Direct | Aug 12, 2026 (92d) |
| May 12, 2026 | VERA | ↓ Sell | 18,500 | $36.74 | $680K | Direct | May 13, 2026 (1d) |
| Feb 23, 2026 | VERA | ↓ Sell | 16,925 | $41.98 | $711K | Direct | Feb 25, 2026 (2d) |
| Feb 26, 2025 | VERA | ↓ Sell | 19,688 | $27.78 | $547K | Direct | Feb 27, 2025 (1d) |
| Jan 8, 2025 | VERA | ↓ Sell | 17,500 | $41.74 | $731K | Direct | Jan 10, 2025 (2d) |
| Dec 18, 2024 | VERA | ↓ Sell | 17,500 | $43.07 | $754K | Direct | Dec 20, 2024 (2d) |
| Dec 11, 2024 | VERA | ↓ Sell | 17,500 | $46.94 | $822K | Direct | Dec 13, 2024 (2d) |
| Nov 25, 2024 | VERA | ↓ Sell | 19,375 | $47.98 | $930K | Direct | Nov 27, 2024 (2d) |
| Nov 13, 2024 | VERA | ↓ Sell | 30,625 | $49.50 | $1.5M | Direct | Nov 15, 2024 (2d) |
| Oct 23, 2024 | VERA | ↓ Sell | 19,375 | $40.39 | $783K | Direct | Oct 25, 2024 (2d) |
| Oct 9, 2024 | VERA | ↓ Sell | 15,625 | $38.24 | $598K | Direct | Oct 11, 2024 (2d) |
| Sep 25, 2024 | VERA | ↓ Sell | 23,125 | $46.05 | $1.1M | Direct | Sep 27, 2024 (2d) |
| Sep 11, 2024 | VERA | ↓ Sell | 15,625 | $37.50 | $586K | Direct | Sep 13, 2024 (2d) |
| Aug 28, 2024 | VERA | ↓ Sell | 30,320 | $36.84 | $1.1M | Direct | Aug 30, 2024 (2d) |
| Aug 21, 2024 | VERA | ↓ Sell | 14,471 | $39.76 | $575K | Direct | Aug 23, 2024 (2d) |
| Aug 14, 2024 | VERA | ↓ Sell | 15,625 | $37.56 | $587K | Direct | Aug 16, 2024 (2d) |
| Aug 21, 2023 | VERA | ↓ Sell | 5,210 | $16.66 | $87K | Direct | Aug 23, 2023 (2d) |
| Oct 4, 2022 | VERA | ↓ Sell | 32,000 | $20.90 | $669K | Direct | Oct 5, 2022 (1d) |
| Sep 13, 2022 | VERA | ↓ Sell | 22,363 | $21.16 | $473K | Direct | Sep 14, 2022 (1d) |
| Sep 12, 2022 | VERA | ↓ Sell | 29,022 | $20.43 | $593K | Direct | Sep 13, 2022 (1d) |
| Sep 8, 2022 | VERA | ↓ Sell | 21,891 | $20.37 | $446K | Direct | Sep 9, 2022 (1d) |
| Sep 2, 2022 | VERA | ↓ Sell | 34,196 | $21.09 | $721K | Direct | Sep 6, 2022 (4d) |
| Aug 12, 2022 | VERA | ↓ Sell | 20,528 | $20.16 | $414K | Direct | Aug 15, 2022 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VERA insiders
Open-market trades in the last 12 months
About Marshall Fordyce's insider trades
Marshall Fordyce is President and CEO at Vera Therapeutics (VERA). Since Aug 12, 2022, Marshall has reported no open-market purchases and 29 sales worth $22.7M on SEC Form 4. In the last 12 months: 9 sales ($8.7M).
Their filings also include option exercises (24 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VERA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.